scholarly journals Predictors of survival in prostate cancer patients with bone metastasis and extremely high prostate-specific antigen levels

2015 ◽  
Vol 3 (1) ◽  
pp. 10-15 ◽  
Author(s):  
Kyo Chul Koo ◽  
Sang Un Park ◽  
Ki Hong Kim ◽  
Koon Ho Rha ◽  
Sung Joon Hong ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Bone Metastasis ◽  
Cancer Patients ◽  
Prostate Specific Antigen ◽  
Specific Antigen

scholarly journals Predictive value of serum prostate specific antigen in detecting bone metastasis in prostate cancer patients using bone scintigraphy

2012 ◽  
Vol 27 (2) ◽  
pp. 81 ◽  
Author(s):  
BhagwantRai Mittal ◽  
Chidambaram NatrajanBalasubramanian Harisankar ◽  
Anish Bhattacharya ◽  
ShrawanKumar Singh ◽  
ArupK Mandal ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Bone Metastasis ◽  
Cancer Patients ◽  
Prostate Specific Antigen ◽  
Bone Scintigraphy ◽  
Predictive Value ◽  
Specific Antigen ◽  
Serum Prostate Specific Antigen

scholarly journals Predicting Bone Metastasis in Prostate Cancer Patients: Value of Prostate Specific Antigen

2008 ◽  
Vol 20 (4) ◽  
pp. 291-295 ◽  
Author(s):  
Ling-Huei Wei ◽  
Jainn-Shiun Chiu ◽  
Shiou-Ying Chang ◽  
Yuh-Feng Wang
Keyword(s):  
Prostate Cancer ◽  
Bone Metastasis ◽  
Cancer Patients ◽  
Prostate Specific Antigen ◽  
Specific Antigen

scholarly journals PREDICTIVE VALUE OF SERUM PROSTATE SPECIFIC ANTIGEN IN DETECTING BONE METASTASIS IN PROSTATE CANCER

2021 ◽  
Vol 28 (2) ◽  
pp. 116-119
Author(s):  
Raden Danarto ◽  
Indwiani Astuti ◽  
Sofia Mubarika Haryana
Keyword(s):  
Prostate Cancer ◽  
Bone Metastasis ◽  
Cancer Patients ◽  
Prostate Specific Antigen ◽  
Predictive Value ◽  
Medical Records ◽  
Bone Scan ◽  
Specific Antigen ◽  
Skeletal Metastasis ◽  
Physical Burden

Objective: We determine the utility of Prostate Specific Antigen (PSA) for predicting the presence of skeletal metastasis on Bone Scan (BS) in prostate cancer patients. Material & Methods: Retrospective analysis of medical records of 70 consecutive prostate cancer patients subjected to bone scan during the last 2 years was done. 5 cases were excluded due to the following reasons: Serum PSA not available, hormonal or other therapy given prior to serum PSA measurement, and/or Bone Scan, and symptomatic for bone metastasis. In remaining 65 cases, PSA value and bone scan were evaluated. Results: BS was found to be positive in 20/65 (31%) and negative in 45(69%) patients. 24 (37%) had serum PSA > 100 ng/ml, 25 (38.5%) had PSA of 20‐100 ng/ml and only 16 (24.5%) had PSA < 20 ng/ml. Conclusion: Serum PSA < 20 ng/ml have high predictive value in ruling out skeletal metastasis. Our data are in corroboration with results from previous studies that BS should be performed only if PSA > 20 ng/ml. Using this cut‐off, unnecessary investigation can be avoided. Avoiding BS asymptomatic in this group of patients would translate into a significant cost‐saving and reduction in their psychological and physical burden.

Sign in / Sign up

Export Citation Format

Share Document